PharmaCorp Rx Inc. (TSXV:PCRX)
Canada · Delayed Price · Currency is CAD 0.4100
0.00 (0.00%)
At close: Nov 28, 2025
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 68.44 million as of December 1, 2025. Its market cap has decreased by -18.72% in one year.
Market Cap
68.44M
Enterprise Value
67.97M
Revenue
17.60M
Ranking
n/a
PE Ratio
253.87
Stock Price
0.41
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 68.44M, an increase of 2,751.66%. That is a compound annual growth rate of 188.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 68.44M | 8.05% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
| Sep 29, 2022 | 2.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.45B |
| dentalcorp Holdings | 2.18B |
| Sienna Senior Living | 1.95B |
| Green Thumb Industries | 1.93B |
| Extendicare | 1.76B |
| Cronos Group | 1.33B |
| Trulieve Cannabis | 1.27B |
| WELL Health Technologies | 977.45M |